With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster status, deal-making is becoming increasingly vital for pharmaceutical companies to offset rising Research and Development (R&D) costs, says business intelligence provider GBI Research.
The company’s latest CBR Pharma report* states that pharmaceutical companies are considering various strategies to overcome the current challenges, which also include shifts in patent laws
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
BioMaryland Center Awards $1.5M to Johns Hopkins and 7 Biotech Companies
Governor Martin O’Malley announced today that the State, through the BioMaryland Center, has awarded nearly $1.5 million to seven innovative life sciences companies and one educational institution through its Biotechnology Development Awards program. The companies, which received up to $200,000 each, will use the funding to accelerate the commercialization of a wide range of treatments and technologies; including a device that detects concussions in youths engaged in sports; a tool that takes a
Read More
